ZAI LAB LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.91 USD | +1.08% |
|
+13.08% | -41.79% |
| 04-17 | Asian Equities Traded in the US as American Depositary Receipts Remain Flat in Wednesday Trading | MT |
| 04-11 | Zai Lab CEO, Others 'Do Not Anticipate' Selling Company Shares in Remainder of 2024 | MT |
Chart calendar Zai Lab Limited
fe1a96ade00caea321.kWGeZEhlJoN8xlwIWHkF-0ROHqLjxf6qrcMRGf33ECA.wQWvMh0MV_pF82w7OklAzRE4aviAqJ_4yo1CabeDIlrbOcpXfyRpwTKqGQ~b65328052196a656ea05c830c65a98ce
Upcoming events on Zai Lab Limited
Past events on Zai Lab Limited
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Progress 2, CT155 / 6 |
| 08/04/2024 21:30 | American Association for Cancer Research Meeting - Progress 2, CT162 / 13 |
| 22/03/2024 11:00 | European Lung Cancer Congress |
| 18/03/2024 22:24 | Society for Gynecologic Oncology Meeting |
| 11/03/2024 20:00 | Leerink Partners Global Biopharma Conference |
| 09/03/2024 15:13 | European Society of Gynaecological Oncology Meeting |
| 28/02/2024 13:00 | Q4 2023 Earnings Call |
| 27/02/2024 21:05 | Q4 2023 Earnings Release |
| 08/01/2024 23:45 | JPMorgan Healthcare Conference |
| 29/11/2023 17:55 | Evercore ISI HealthCONx Conference |
| 15/11/2023 13:00 | Jefferies London Healthcare Conference |
| 08/11/2023 13:00 | Q3 2023 Earnings Call |
| 07/11/2023 21:05 | Q3 2023 Earnings Release |
| 27/09/2023 13:00 | Cantor Global Healthcare Conference |
| 06/09/2023 15:30 | Citi BioPharma Conference |
| 08/08/2023 13:00 | Q2 2023 Earnings Call |
| 07/08/2023 21:05 | Q2 2023 Earnings Release |
| 20/06/2023 14:00 | Investor Day |
| 20/06/2023 13:00 | Annual General Meeting |
| 14/06/2023 22:00 | Goldman Sachs Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 13,0 9,26 40.23% | 49,0 56,3 -12.98% | 144 147 -2.08% | 215 216 -0.63% | 267 269 -0.77% | 379 |
|
EBITDA Million USD | Released Forecast Spread | -199 -145 -37.87% | -297 -249 -19.43% | -694 -614 -12.89% | -396 -425 6.86% | -358 -342 -4.68% | -331 |
|
EBIT Million USD | Released Forecast Spread | -203 -173 -17.38% | -302 -259 -16.31% | -700 -599 -16.82% | -404 -425 4.87% | -367 -351 -4.32% | -338 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -194 -120 -61.26% | -268 -259 -3.42% | -703 -613 -14.83% | -443 -463 4.37% | -335 -354 5.6% | -319 |
|
Net income Million USD | Released Forecast Spread | -195 -157 -23.93% | -269 -257 -4.55% | -704 -589 -19.52% | -443 -460 3.55% | -335 -348 3.74% | -317 |
|
EPS USD | Released Forecast Spread | -3,03 -2,61 -16.26% | -3,46 -3,18 -8.8% | -7,58 -6,87 -10.27% | -4,63 -4,93 6.02% | -3,46 -3,47 0.18% | -3,27 |
| Announcement Date | 19/03/20 | 01/03/21 | 01/03/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S1 | 2020 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,56 14,8 -35.37% | 19,2 16,7 14.78% | 29,7 27,2 9.25% | 57,0 55,7 2.32% | 44,2 51,1 -13.51% | 87,3 86,7 0.64% | 46,7 45,7 2.19% | 48,2 47,1 2.23% | 94,9 89,5 5.99% | 57,5 53,7 7.1% | 62,6 62,3 0.56% | 120 123 -2.04% | 62,8 65,5 -4.09% | 68,9 70,7 -2.56% | 69,2 66,7 3.84% | 65,8 72,1 -8.7% | 75,2 | 85,5 | 99,2 | 120 |
|
EBITDA Million USD | Released Forecast Spread | -217 -96,2 -125.96% | -77,8 -146 46.67% | -122 -81,0 -50.07% | -105 | -91,2 | -82,4 | -66,3 | |||||||||||||
|
EBIT Million USD | Released Forecast Spread | -117 -81,6 -43.84% | -130 -125 -4.58% | -172 -147 -16.57% | -398 -391 -1.6% | -219 -122 -80.01% | -302 -290 -4.16% | -79,8 -120 33.75% | -98,7 -102 2.9% | -178 -179 0.28% | -129 -112 -14.47% | -97,3 -108 10.22% | -226 -256 11.89% | -69,5 -93,3 25.51% | -89,5 -88,8 -0.84% | -83,6 -103 19.02% | -124 -89,0 -39.31% | -96,8 | -92,9 | -86,0 | -78,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -111 -93,0 -19.79% | -128 -130 1.57% | -140 -145 3.81% | -211 -118 -78.48% | -82,2 -89,1 7.77% | -138 -103 -34.44% | -161 -125 -29.02% | -61,8 -106 41.95% | -49,1 -90,2 45.54% | -121 -72,8 -66.06% | -69,2 -89,0 22.3% | -95,4 -81,0 -17.77% | -93,1 | -88,6 | -81,7 | -67,2 | ||||
|
Net income Million USD | Released Forecast Spread | -112 -92,8 -20.47% | -129 -130 1.35% | -140 -145 3.32% | -212 -130 -63.35% | -82,4 -117 29.43% | -138 -102 -35.39% | -161 -122 -31.74% | -61,8 -107 42.22% | -223 -183 -21.84% | -49,1 -90,0 45.41% | -121 -72,3 -67.14% | -69,2 -91,2 24.15% | -95,4 -84,8 -12.57% | -91,7 | -87,1 | -79,1 | -66,9 | |||
|
EPS USD | Released Forecast Spread | -1,66 -1,42 -16.9% | -1,74 -1,75 0.29% | -1,72 -1,71 -0.39% | -2,24 -1,38 -62.57% | -0,86 -1,14 24.78% | -1,44 -1,06 -35.96% | -1,68 -1,27 -32.43% | -0,65 -1,12 41.72% | -0,51 -0,93 45.31% | -1,25 -0,75 -67.66% | -0,71 -0,94 24.44% | -0,98 -0,87 -12.69% | -0,94 | -0,89 | -0,81 | -0,68 | ||||
| Announcement Date | 19/03/20 | 13/08/20 | 01/03/21 | 09/08/21 | 01/03/22 | 01/03/22 | 10/05/22 | 09/08/22 | 09/08/22 | 09/11/22 | 01/03/23 | 01/03/23 | 09/05/23 | 07/08/23 | 07/11/23 | 27/02/24 | - | - | - | - |
More events
Past sector events for Zai Lab Limited
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZLAB Stock
- Calendar Zai Lab Limited
